Asthma
Asthma Inpatient Management
search
Asthma Inpatient Management
See Also
Pediatric Asthma Score
Asthma Education
Asthma Management
Asthma Exacerbation Home Management
Emergency Management of Asthma Exacerbation
Status Asthmaticus
Asthma-Related Death Risk Factors
Asthma Differential Diagnosis
Evaluation
Vital Sign
Monitoring
See
Pediatric Asthma Score
Vital Sign
s: Temp,
Pulse
,
Blood Pressure
, Respirations
Start with every 4 hours for 12 hours
Space to every 6 hours
Peak Expiratory Flow
(
PEFR
)
PEFR
accurate age >7 years (may be helpful age > 5)
Obtain at least twice daily
Peak Flow
s at one hour following
Bronchodilator
Oxygen Saturation
Monitor
Oxygen to keep
Oxygen Saturation
adequate
Adults: >93%
Children: >95%
Discontinuation Criteria
Oxygen Saturation
adequate for 4 hours
Patient on general ward
Continue spot check
Oxygen Saturation
Perform with
Vital Sign
s
As needed for respiratory distress
Telemetry monitor (cardiac monitor) Indications
Albuterol Nebulizer
more than every 4 hours
Infant or young child
Corroborate
Oxygen Saturation
monitor (match pulse)
Child movement makes
Oxygen Saturation
inaccurate
Management
Medications
See
Emergency Management of Asthma Exacerbation
See
Status Asthmaticus
Bronchodilator
s
See
Albuterol
Albuterol
MDI or
Albuterol Nebulizer
every 4 to 6 hours as needed
Consider adding
Muscarinic Antagonist
(
Ipratropium Bromide
, duonebs)
Corticosteroid
s
Methylprednisolone
(
Solu-Medrol
)
Dose: 1 mg/kg/dose q6 hours
Maximum Dose: 60 mg IV q6 hour OR 80 mg IV q8 hours
Oral
Prednisone
Indications to switch from
Solu-Medrol
Albuterol Nebulizer
spaced to 4 hours or more
Tolerating oral intake (No
Nausea
or
Vomiting
)
Dose
Prednisone
1-2 mg/kg/day qd-bid
Maximum: 40-60 mg/day for 5-10 days
No tapering needed if use less than 2 weeks
Evaluation
Monitoring
Peak Expiratory Flow
(PEF) or
FEV1
Obtain one hour after
Bronchodilator
doses
Target improvement of >60% of predicted (or personal best)
Venous Blood Gas
or
Arterial Blood Gas
Indications (on admission)
Pulmonary Function Test
Criteria
PEFR
< 30%
Prior history of pCO2 > 40
Failure to improve in 4 hours of therapy
Clinical
Asthma
score >7
Indications to monitor serum
Electrolyte
s
Nausea
or
Vomiting
Intravenous Fluid
s for more than 24 hours
Beta
Agonist
s more than every 4 hours for 24 hours
Chest XRay
Indications
First episode
Wheezing
Marked Breath Sound asymmetry
History or exam suggestive of
Pneumonia
Findings
Signs of Improvement
Minimal or no
Wheezing
Caution that silent lungs also occurs in
Status Asthmaticus
prior to respiratory arrest
Less than 2 night awakenings for
Mild Asthma
symptoms
Good activity tolerance
Peak Expiratory Flow
(
PEFR
) or
FEV1
> 60% of predicted or baseline
Adequate
Oxygen Saturation
>93 to 94% (off
Supplemental Oxygen
)
Pediatric Asthma Score
(PAS): 5 to 7
Signs of Worsening (consider ICU transfer)
See
Status Asthmaticus
Altered Level of Consciousness
(e.g. drowsiness or confusion)
Decreased breath sounds (quiet lungs) with decreased work of breathing despite clinical worsening
Persistent or progressive
Hypoxia
Failure to improve after first 6-12 hours of management (including
Corticosteroid
s)
Pediatric Asthma Score
(PAS): >7 (and esp. >11)
Management
Discharge
See
Asthma-Related Death Risk Factors
Indications
Inhaled Beta Agonist
no more then every 4 hours
Parenteral
Corticosteroid
s switched to Oral
Corticosteroid
s
Adequate
Oxygen Saturation
>93 to 94% (on room air)
Peak Expiratory Flow
(
PEFR
) or
FEV1
> 60% of predicted or baseline
Pediatric Asthma Score
(PAS): 5 to 7
Asthma Education
: Medication use
Inhaled Corticosteroid
by bedside
Respiratory Therapy or nurse to instruct use bid
Peak Flow
measurement at home
Outpatient Management
Continue short-acting
Bronchodilator
as needed (or advance
SMART Asthma Management Protocol
)
Assess for proper
Inhaler
use with spacer
Review
Asthma Action Plan
Start or step-up controller medication
Continue oral
Corticosteroid
s for 3 to 5 days in children (5 to 7 days in adults)
Follow-up
Clinic appointment within 7-10 days
References
(1997) Management of
Asthma
, NIH 97-4053
(1995) Global Strategy for
Asthma
, NIH 95-3659
Dabbs (2024) Am Fam Physician 109(1): 43-50 [PubMed]
Pollart (2011) Am Fam Physician 84(1): 40-7 [PubMed]
Type your search phrase here